{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:06:00Z","timestamp":1788455160101,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interstitial lung disease (ILD) is a progressive fibrotic disease associated with rheumatoid arthritis (RA); real-world data for evaluating RA\u2013associated ILD (RA\u2013ILD) are limited. We evaluated prevalence, time to onset, clinical characteristics and prognostic factors in patients diagnosed with RA (n\u2009=\u20098963) in the Discus Analytics JointMan database (2009\u20132019) with and without ILD. ILD prevalence was 4.1% (95% confidence interval 3.7\u20134.5);\u2009&gt;\u200990% had an ILD diagnosis after RA diagnosis (mean time to onset 3.3\u00a0years). At baseline, a higher proportion of patients with RA\u2013ILD were older (&gt;\u200965\u00a0years), male, with history of chronic obstructive pulmonary disease (COPD) compared with patients in the RA cohort. Patients in the RA\u2013ILD cohort were likely to have more severe RA characteristics and joint evaluation compared with patients without ILD, at baseline and before\/after ILD diagnosis. In this large, real-world database patients with (vs without) ILD had a higher burden of RA characteristics. Previously established risk factors for RA\u2013ILD were confirmed (age, baseline COPD, anti-cyclic citrullinated peptide positivity, C-reactive protein, Clinical Disease Activity Index score); thus, recognition of these factors and tracking routine disease activity metrics may help identify patients at higher risk of RA complications and lead to improved diagnosis and earlier treatment.<\/jats:p>","DOI":"10.1038\/s41598-023-37452-y","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T18:33:51Z","timestamp":1689791631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database"],"prefix":"10.1038","volume":"13","author":[{"given":"Joe","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonie","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lovett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"37452_CR1","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","volume":"37","author":"TM Hunter","year":"2017","unstructured":"Hunter, T. M. et al. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004\u20132014. Rheumatol. Int. 37, 1551\u20131557. https:\/\/doi.org\/10.1007\/s00296-017-3726-1 (2017).","journal-title":"Rheumatol. Int."},{"key":"37452_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","volume":"44","author":"E Bodolay","year":"2005","unstructured":"Bodolay, E. et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 44, 656\u2013661. https:\/\/doi.org\/10.1093\/rheumatology\/keh575 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR3","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","volume":"58","author":"AC Duarte","year":"2019","unstructured":"Duarte, A. C., Porter, J. C. & Leandro, M. J. The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment. Rheumatology (Oxford) 58, 2031\u20132038. https:\/\/doi.org\/10.1093\/rheumatology\/kez177 (2019).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo, K. et al. Rheumatoid arthritis-interstitial lung disease in the United States: Prevalence, incidence, and healthcare costs and mortality. J. Rheumatol. 46, 360\u2013369. https:\/\/doi.org\/10.3899\/jrheum.171315 (2019).","journal-title":"J. Rheumatol."},{"key":"37452_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson, A. L. et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am. J. Respir. Crit. Care Med. 183, 372\u2013378. https:\/\/doi.org\/10.1164\/rccm.201004-0622OC (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"37452_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico, B. R. et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch. Intern. Med. 168, 159\u2013166. https:\/\/doi.org\/10.1001\/archinternmed.2007.59 (2008).","journal-title":"Arch. Intern. Med."},{"key":"37452_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/kes262","volume":"52","author":"S Norton","year":"2013","unstructured":"Norton, S. et al. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford) 52, 99\u2013110. https:\/\/doi.org\/10.1093\/rheumatology\/kes262 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/ard.62.9.897","volume":"62","author":"L Carmona","year":"2003","unstructured":"Carmona, L. et al. Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Ann. Rheum. Dis. 62, 897\u2013900. https:\/\/doi.org\/10.1136\/ard.62.9.897 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"37452_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay, E. et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am. J. Respir. Crit. Care Med. 156, 528\u2013535. https:\/\/doi.org\/10.1164\/ajrccm.156.2.9609016 (1997).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"37452_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib, H. M., Eisa, A. A., Arafat, W. R. & Marie, M. A. Pulmonary involvement in early rheumatoid arthritis patients. Clin. Rheumatol. 30, 217\u2013221. https:\/\/doi.org\/10.1007\/s10067-010-1492-5 (2011).","journal-title":"Clin. Rheumatol."},{"key":"37452_CR11","doi-asserted-by":"publisher","first-page":"406927","DOI":"10.1155\/2013\/406927","volume":"2013","author":"J Chen","year":"2013","unstructured":"Chen, J., Shi, Y., Wang, X., Huang, H. & Ascherman, D. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin. Dev. Immunol. 2013, 406927. https:\/\/doi.org\/10.1155\/2013\/406927 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"37452_CR12","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","volume":"74","author":"PA Juge","year":"2022","unstructured":"Juge, P. A. et al. A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheumatol. 74, 1755\u20131765. https:\/\/doi.org\/10.1002\/art.42162 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"37452_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz, T. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum. 62, 1583\u20131591. https:\/\/doi.org\/10.1002\/art.27405 (2010).","journal-title":"Arthritis Rheum."},{"key":"37452_CR14","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard, C. et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: Comorbidity and mortality. Ann. Rheum. Dis. 76, 1700\u20131706. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"37452_CR15","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","volume":"11","author":"E Cano-Jimenez","year":"2021","unstructured":"Cano-Jimenez, E. et al. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis. Sci. Rep. 11, 9184. https:\/\/doi.org\/10.1038\/s41598-021-88734-2 (2021).","journal-title":"Sci. Rep."},{"key":"37452_CR16","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly, C. A. et al. Rheumatoid arthritis-related interstitial lung disease: Associations, prognostic factors and physiological and radiological characteristics\u2014A large multicentre UK study. Rheumatology (Oxford) 53, 1676\u20131682. https:\/\/doi.org\/10.1093\/rheumatology\/keu165 (2014).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR17","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/s2665-9913(22)00380-0","volume":"5","author":"VL Kronzer","year":"2023","unstructured":"Kronzer, V. L. et al. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. Lancet Rheumatol. 5, e77\u2013e87. https:\/\/doi.org\/10.1016\/s2665-9913(22)00380-0 (2023).","journal-title":"Lancet Rheumatol."},{"key":"37452_CR18","doi-asserted-by":"publisher","first-page":"e028466","DOI":"10.1136\/bmjopen-2018-028466","volume":"9","author":"P Kiely","year":"2019","unstructured":"Kiely, P. et al. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts. BMJ Open 9, e028466. https:\/\/doi.org\/10.1136\/bmjopen-2018-028466 (2019).","journal-title":"BMJ Open"},{"key":"37452_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh, J. A. et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 68, 1\u201326. https:\/\/doi.org\/10.1002\/art.39480 (2016).","journal-title":"Arthritis Care Res."},{"key":"37452_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue, E., Yamanaka, H., Hara, M., Tomatsu, T. & Kamatani, N. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann. Rheum. Dis. 66, 407\u2013409. https:\/\/doi.org\/10.1136\/ard.2006.054205 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"37452_CR21","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3899\/jrheum.080182","volume":"35","author":"T Pincus","year":"2008","unstructured":"Pincus, T., Swearingen, C. J., Bergman, M. & Yazici, Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: Proposed severity categories compared to disease activity score and clinical disease activity index categories. J. Rheumatol. 35, 2136\u20132147. https:\/\/doi.org\/10.3899\/jrheum.080182 (2008).","journal-title":"J. Rheumatol."},{"key":"37452_CR22","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1002\/art.11407","volume":"49","author":"J Fransen","year":"2003","unstructured":"Fransen, J., Stucki, G. & van Riel, P. L. C. M. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care Res. (Hoboken) 49, S214\u2013S224. https:\/\/doi.org\/10.1002\/art.11407 (2003).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"37452_CR23","unstructured":"International Society for Pharmacoepidemiology. Guidelines for Good Pharmacoepidemiology Practices (GPP). 2020 (2016). https:\/\/www.pharmacoepi.org\/resources\/policies\/guidelines-08027\/."},{"key":"37452_CR24","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1093\/rheumatology\/keaa836","volume":"60","author":"JA Sparks","year":"2021","unstructured":"Sparks, J. A. et al. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford) 60, 3689\u20133698. https:\/\/doi.org\/10.1093\/rheumatology\/keaa836 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.5455\/medarh.2020.74.450-454","volume":"74","author":"DM Alsharari","year":"2020","unstructured":"Alsharari, D. M. et al. Rheumatoid arthritis interstitial lung disease: Measuring and predictive factors among patients treated in rehabilitation clinics at Royal Medical Services. Med. Arch. 74, 450\u2013454. https:\/\/doi.org\/10.5455\/medarh.2020.74.450-454 (2020).","journal-title":"Med. Arch."},{"key":"37452_CR26","doi-asserted-by":"publisher","first-page":"e17088","DOI":"10.1097\/MD.0000000000017088","volume":"98","author":"F Salaffi","year":"2019","unstructured":"Salaffi, F., Carotti, M., Di Carlo, M., Tardella, M. & Giovagnoni, A. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities. Medicine (Baltimore) 98, e17088. https:\/\/doi.org\/10.1097\/MD.0000000000017088 (2019).","journal-title":"Medicine (Baltimore)"},{"key":"37452_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","volume":"73","author":"JT Giles","year":"2014","unstructured":"Giles, J. T. et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann. Rheum. Dis. 73, 1487\u20131494. https:\/\/doi.org\/10.1136\/annrheumdis-2012-203160 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"37452_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1513\/AnnalsATS.202006-590OC","volume":"18","author":"JG Natalini","year":"2021","unstructured":"Natalini, J. G. et al. Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S. veterans. Ann. Am. Thorac. Soc. 18, 598\u2013605. https:\/\/doi.org\/10.1513\/AnnalsATS.202006-590OC (2021).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"37452_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12016-020-08819-0","volume":"60","author":"RX Chen","year":"2021","unstructured":"Chen, R. X. et al. Distinctive clinical characteristics and outcome of ILD-onset rheumatoid arthritis and ACPA-positive ILD: A longitudinal cohort of 282 cases. Clin. Rev. Allergy Immunol. 60, 46\u201354. https:\/\/doi.org\/10.1007\/s12016-020-08819-0 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"37452_CR30","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.55563\/clinexprheumatol\/i9au1r","volume":"40","author":"B Zheng","year":"2022","unstructured":"Zheng, B. et al. Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis. Clin. Exp. Rheumatol. 40, 1280\u20131284. https:\/\/doi.org\/10.55563\/clinexprheumatol\/i9au1r (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"37452_CR31","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1007\/s10067-021-05854-w","volume":"40","author":"M Tardella","year":"2021","unstructured":"Tardella, M., Di Carlo, M., Carotti, M., Giovagnoni, A. & Salaffi, F. Abatacept in rheumatoid arthritis-associated interstitial lung disease: Short-term outcomes and predictors of progression. Clin. Rheumatol. 40, 4861\u20134867. https:\/\/doi.org\/10.1007\/s10067-021-05854-w (2021).","journal-title":"Clin. Rheumatol."},{"key":"37452_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4046\/trd.2021.0141","volume":"85","author":"JY Choi","year":"2022","unstructured":"Choi, J. Y., Song, J. W. & Rhee, C. K. Chronic obstructive pulmonary disease combined with interstitial lung disease. Tuberc. Respir. Dis. (Seoul) 85, 122\u2013136. https:\/\/doi.org\/10.4046\/trd.2021.0141 (2022).","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"key":"37452_CR33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/art.40904","volume":"71","author":"JA Sparks","year":"2019","unstructured":"Sparks, J. A. et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: A prospective cohort study. Arthritis Rheumatol. 71, 1472\u20131482. https:\/\/doi.org\/10.1002\/art.40904 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"37452_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","volume":"17","author":"F Paulin","year":"2021","unstructured":"Paulin, F. et al. Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis. Reumatol. Clin. (Engl. Ed.) 17, 207\u2013211. https:\/\/doi.org\/10.1016\/j.reuma.2019.05.007 (2021).","journal-title":"Reumatol. Clin. (Engl. Ed.)"},{"key":"37452_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3899\/jrheum.200863","volume":"48","author":"VL Kronzer","year":"2021","unstructured":"Kronzer, V. L. et al. Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease. J. Rheumatol. 48, 656\u2013663. https:\/\/doi.org\/10.3899\/jrheum.200863 (2021).","journal-title":"J. Rheumatol."},{"key":"37452_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3904\/kjim.2016.349","volume":"34","author":"JA Yang","year":"2019","unstructured":"Yang, J. A. et al. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis. Korean J. Intern. Med. 34, 434\u2013441. https:\/\/doi.org\/10.3904\/kjim.2016.349 (2019).","journal-title":"Korean J. Intern. Med."},{"issue":"Suppl 7","key":"37452_CR37","doi-asserted-by":"publisher","first-page":"vii54","DOI":"10.1093\/rheumatology\/key109","volume":"57","author":"S Monti","year":"2018","unstructured":"Monti, S., Grosso, V., Todoerti, M. & Caporali, R. Randomized controlled trials and real-world data: Differences and similarities to untangle literature data. Rheumatology (Oxford) 57(Suppl 7), vii54\u2013vii58. https:\/\/doi.org\/10.1093\/rheumatology\/key109 (2018).","journal-title":"Rheumatology (Oxford)"},{"key":"37452_CR38","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","volume":"43","author":"H Quan","year":"2008","unstructured":"Quan, H. et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv. Res. 43, 1424\u20131441. https:\/\/doi.org\/10.1111\/j.1475-6773.2007.00822.x (2008).","journal-title":"Health Serv. Res."},{"key":"37452_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/acr2.1021","volume":"1","author":"CM Bradford","year":"2019","unstructured":"Bradford, C. M. et al. Characterization of a subset of patients with rheumatoid arthritis for whom current management strategies are inadequate. ACR Open Rheumatol. 1, 145\u2013155. https:\/\/doi.org\/10.1002\/acr2.1021 (2019).","journal-title":"ACR Open Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37452-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37452-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T19:00:18Z","timestamp":1689793218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-37452-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37452"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-37452-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Z. and S.L. are employees of and\/or shareholders in Bristol Myers Squibb. K.K. is a former employee of Discus Analytics and is currently employed by TargetRWE. C.G. is an employee of STATinMED Research. K.L. is a former employee of STATinMED Research and is currently employed by Aetion, Inc. S.T. was a doctoral student at the University of North Carolina at Chapel Hill, Gillings School of Global Public Health completing a pre-doctoral fellowship with Bristol Myers Squibb at the time of this study and is currently employed by University of North Carolina at Chapel Hill, Gillings School of Global Public Health. G.L.C. is a partner at Arthritis Northwest, a board member and shareholder of Discus Analytics, and has undertaken consulting work and been on a speakers bureau for Bristol Myers Squibb.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11678"}}